Exactly. And as it has been pointed out, Min is presently in preclinical studies. All is going well. They are setting up to submit the FDA IND application for Min very soon. From a market potential perspective, that is where the moon really comes in.

Have most forgotten that they are presently in pre clinical studies for Min? And that they are dovetailing this with the Benetic science? Why are people panicking because there has yet to be an FDA approval confirmation on Hema?